A Longitudinal Study of Head Circumference Trajectories in Autism and Autistic Traits.

A Longitudinal Study of Head Circumference Trajectories in Autism and Autistic Traits.

Publication date: Oct 12, 2024

Increased head circumference is an established finding in autism spectrum disorder (ASD); however, it is unclear when this increase occurs, if it persists and whether it manifests across the whole ASD spectrum. Head circumference is a strong predictor of brain size and can therefore provide key insights into brain development in ASD. We used data from the Avon Longitudinal Study of Parents and Children to compare head circumference trajectories from birth to 15 years in children with an ASD diagnosis (N = 78, controls = 6,404) or elevated autistic traits as measured using the Social Communication Disorder Checklist (N = 639, controls = 6,230). Exploratory analyses were conducted in those with ASD and co-morbid cognitive learning needs (CLN). Children with an ASD diagnosis had larger head circumference from birth across childhood and adolescence compared to controls in univariable (B = 0. 69, 95% confidence interval [CI]: 0. 28-1. 09, p = 0. 001) and multivariable models (B = 0. 38, 95% CI: 0. 003-0. 75, p = 0. 048). Differences were more marked in those with co-morbid CLN. Children with elevated autistic traits had significantly smaller head circumference compared to controls. There was weak evidence of group differences when height was included as a covariate. Head circumference trajectories in ASD deviate from control children and persist until adolescence. Autistic traits were associated with smaller head circumference, suggesting distinct growth trajectories between clinical cases from those with non-clinical traits.

Open Access PDF

Concepts Keywords
Autism ALSPAC
Birth Autism
Models Head Circumference
Morbid Longitudinal
Neurodevelopmental

Semantics

Type Source Name
disease MESH Autism
disease MESH autism spectrum disorder
disease MESH Social Communication Disorder
drug DRUGBANK Adenosine
disease MESH neurodevelopmental disorder
drug DRUGBANK Coenzyme M
drug DRUGBANK Pumactant
drug DRUGBANK Methionine
drug DRUGBANK Cysteamine
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH dyslexia
disease MESH dyspraxia
disease MESH level of education
disease MESH tic
drug DRUGBANK Trestolone
disease MESH cognitive impairments
disease MESH weight gain
disease MESH macrocephaly
disease MESH Asperger disorder
disease MESH Microcephaly
drug DRUGBANK Polyethylene glycol
pathway REACTOME Reproduction
disease MESH Intellectual disability

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *